Netherlands-based investment firm Forbion raised €2.3 billion ($2.6 billion), the largest amount raised by Europe's life sciences biotech sector this year. About 60% of the funds come from European investors and the remaining 40% from North America. Among the investors are the Dutch pension funds MN and PGGM, the German [...]